Directive 2011/13 - Amendment of Directive 98/8/EC to include nonanoic acid as an active substance in Annex I thereto

Please note

This page contains a limited version of this dossier in the EU Monitor.

1.

Current status

This directive was in effect from March  1, 2011 until August 31, 2013 and should have been implemented in national regulation on January 31, 2012 at the latest.

2.

Key information

official title

Commission Directive 2011/13/EU of 8 February 2011 amending Directive 98/8/EC of the European Parliament and of the Council to include nonanoic acid as an active substance in Annex I thereto Text with EEA relevance
 
Legal instrument Directive
Number legal act Directive 2011/13
CELEX number i 32011L0013

3.

Key dates

Document 08-02-2011
Publication in Official Journal 09-02-2011; OJ L 34, 9.2.2011,Special edition in Croatian: Chapter 13 Volume 048
Effect 01-03-2011; Entry into force Date pub. +20 See Art 3
01-02-2013; Application See Art 2
End of validity 31-08-2013; Repealed by 32012R0528
Transposition 31-01-2012; At the latest See Art 2

4.

Legislative text

9.2.2011   

EN

Official Journal of the European Union

L 34/52

 

COMMISSION DIRECTIVE 2011/13/EU

of 8 February 2011

amending Directive 98/8/EC of the European Parliament and of the Council to include nonanoic acid as an active substance in Annex I thereto

(Text with EEA relevance)

THE EUROPEAN COMMISSION,

Having regard to the Treaty on the Functioning of the European Union,

Having regard to Directive 98/8/EC of the European Parliament and of the Council of 16 February 1998 concerning the placing of biocidal products on the market (1), and in particular the second subparagraph of Article 16(2) thereof,

Whereas:

 

(1)

Commission Regulation (EC) No 1451/2007 of 4 December 2007 on the second phase of the 10-year work programme referred to in Article 16(2) of Directive 98/8/EC of the European Parliament and of the Council concerning the placing of biocidal products on the market (2) establishes a list of active substances to be assessed, with a view to their possible inclusion in Annex I, IA or IB to Directive 98/8/EC. That list includes nonanoic acid.

 

(2)

Pursuant to Regulation (EC) No 1451/2007, nonanoic acid has been evaluated in accordance with Article 11(2) of Directive 98/8/EC for use in product-type 19, repellents and attractants, as defined in Annex V to that Directive.

 

(3)

Austria was designated as Rapporteur Member State and submitted the competent authority report, together with a recommendation, to the Commission on 10 October 2008 in accordance with Article 14(4) and (6) of Regulation (EC) No 1451/2007.

 

(4)

The competent authority report was reviewed by the Member States and the Commission. In accordance with Article 15(4) of Regulation (EC) No 1451/2007, the findings of the review were incorporated, within the Standing Committee on Biocidal Products on 24 September 2010, in an assessment report.

 

(5)

It appears from the evaluations that biocidal products used as repellents and containing nonanoic acid may be expected to satisfy the requirements laid down in Article 5 of Directive 98/8/EC. It is therefore appropriate to include nonanoic acid in Annex I to that Directive.

 

(6)

Not all potential uses have been evaluated at Union level. It is therefore appropriate that Member States assess those uses or exposure scenarios and those risks to the environmental compartments and populations that have not been representatively addressed in the Union level risk assessment and, when granting product authorisations, ensure that appropriate measures are taken or specific conditions imposed in order to reduce the identified risks to acceptable levels.

 

(7)

It is important that the provisions of this Directive be applied simultaneously in all Member States in order to ensure equal treatment of biocidal products on the market containing the active substance nonanoic acid and also to facilitate the proper operation of the biocidal products market in general.

 

(8)

A reasonable period should be allowed to elapse before an active substance is included in Annex I to Directive 98/8/EC in order to permit Member States and the interested parties to prepare themselves to meet the new requirements entailed and to ensure that applicants who have prepared dossiers can benefit fully from the 10-year period of data protection, which, in accordance with Article 12(1)(c)(ii) of Directive 98/8/EC, starts from the date of inclusion.

 

(9)

After inclusion, Member States should be allowed a reasonable period to implement Article 16(3) of Directive 98/8/EC.

 

(10)

Directive 98/8/EC should therefore be amended accordingly.

 

(11)

The measures provided for in this Directive are in accordance with the opinion of the Standing Committee on Biocidal Products...


More

This text has been adopted from EUR-Lex.

 

5.

Sources and disclaimer

For further information you may want to consult the following sources that have been used to compile this dossier:

This dossier is compiled each night drawing from aforementioned sources through automated processes. We have invested a great deal in optimising the programming underlying these processes. However, we cannot guarantee the sources we draw our information from nor the resulting dossier are without fault.

 

6.

Full version

This page is also available in a full version containing the legal context, de Europese rechtsgrond, other dossiers related to the dossier at hand and the related cases of the European Court of Justice.

The full version is available for registered users of the EU Monitor by ANP and PDC Informatie Architectuur.

7.

EU Monitor

The EU Monitor enables its users to keep track of the European process of lawmaking, focusing on the relevant dossiers. It automatically signals developments in your chosen topics of interest. Apologies to unregistered users, we can no longer add new users.This service will discontinue in the near future.